middle.news
How Memphasys Is Driving Felix™ Sales Ahead of CE Mark Approval in Middle East
9:27am on Monday 8th of December, 2025 AEDT
•
Healthcare
Read Story
How Memphasys Is Driving Felix™ Sales Ahead of CE Mark Approval in Middle East
9:27am on Monday 8th of December, 2025 AEDT
Key Points
Direct sales strategy launched targeting IVF clinics in Qatar and UAE
Binding A$390,000 cartridge order from distributor ITL sets revenue baseline
Clinic visits reveal potential for A$100k–A$300k annual recurring revenue per site
Felix™ clinical credibility reinforced at Middle East Fertility Society Conference
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Memphasys (ASX:MEM)
OPEN ARTICLE